Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|June 20, 2007
A pilot study of bendamustine in elderly patients with high-risk MDS and AMLC Strupp, S Knipp, J Hartmann, et al.
European Journal of Haematology|November 28, 2001
Acute basophilic leukemiaA A Giagounidis, B Hildebrandt, M Heinsch, et al.
European Journal of Haematology|February 14, 2004
Thalidomide for the treatment of idiopathic myelofibrosisC Strupp, U Germing, A Scherer, et al.
Annals of Hematology|May 14, 2005
Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroupA A N Giagounidis, U Germing, C Strupp, et al.
European Journal of Haematology|June 20, 2002
Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cellsM Aivado, A Rong, M Stadler, et al.
Annals of Hematology|June 9, 2025
Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS)K Nachtkamp, F Schulz, A Kasprzak, et al.
Oncology Reports|April 18, 2000
Transdermal fentanyl during high-dose chemotherapy and autologous stem cell supportC Strupp, T Sudhoff, U Germing, et al.
Annals of Hematology|November 21, 2022
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blastsA Kasprzak, C Assadi, K Nachtkamp, et al.
Leukemia & Lymphoma|July 16, 2005
The ratio between CD4+ and CD8+ cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomideC Strupp, U Germing, M Aivado, et al.
Der Radiologe|April 20, 2002
[Dynamic contrast-enhanced MRI for evaluating bone marrow microcirculation in malignant hematological diseases before and after thalidomide therapy]A Scherer, C Strupp, H J Wittsack, et al.
Pageof 13